Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer

ERDOĞAR, NAZLI; ESENDAĞLI, GÜNEŞ; Nielsen, Thorbjorn; Esendagli-Yilmaz, Guldal; Yoyen-Ermis, Digdem; Erdogdu, Batuhan; SARGON, MUSTAFA; EROĞLU, HAKAN; BİLENSOY, EREM

doi:10.1080/1061186x.2017.1339194

Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer

Atıf İçin Kopyala

ERDOĞAR N. , ESENDAĞLI G. , Nielsen T. T. , Esendagli-Yilmaz G., Yoyen-Ermis D., Erdogdu B., ...Daha Fazla

JOURNAL OF DRUG TARGETING, cilt.26, ss.66-74, 2018 (SCI İndekslerine Giren Dergi)

Cilt numarası: 26 Konu: 1
Basım Tarihi: 2018
Doi Numarası: 10.1080/1061186x.2017.1339194
Dergi Adı: JOURNAL OF DRUG TARGETING
Sayfa Sayıları: ss.66-74

Özet

Purpose: The aim of this study is to test folate-conjugated cyclodextrin nanoparticles (FCD-1 and FCD-2) as a vehicle for reducing toxicity and increasing the antitumor efficacy of paclitaxel especially for metastatic breast cancer.